Ksana Health’s CEO and Co-Founder Dr. Nick Allen is participating in a panel discussion on recent innovations in mental health measurement, psychedelics, and digital therapies on at SXSW 2022 with Danielle Schlosser at COMPASS Pathways, Arvind Tewari at Atai Life Sciences, and Kate Neiderhoffer at BetterUp.
Two of the most important recent innovations in mental health have been the emergence of digital approaches and the resurgence of scientific interest in the role of psychedelics. These two approaches may have significant synergy. Because psychedelic treatment involves a limited dosing period that can have varying clinical outcomes, digital tools may be especially useful for tracking clinical responses to determine ongoing care. Evidence suggests that psychedelic treatment may create a window of brain plasticity when new learning can occur. Digital therapies could optimize this learning by helping to promote positive changes during this sensitive period. This panel explores these opportunities with experts in digital mental health and modern psychedelic science.
Ksana Health is hosting a powerful afternoon of storytelling featuring stories of resilience, hope, and mental health awareness. The event will create opportunities to dialogue and thoughtfully engage around the true personal stories of those affected by mental health challenges. If you are in Austin or attending SXSW 2022, we’d love for you to attend this exciting event. Reserve tickets here.
9 March 2022
Like any new health technology, continuous behavioral health measurement (CBHM) must economically justify its place among the growing options for measuring therapy and care outcomes. At Ksana Health, we think a lot...Continue reading
In September 2022, Ksana Health founders, Dr. Nick Allen and Will Short are quoted in an industry article highlighting the opportunistic role of remote patient monitoring (RPM) in behavioral health. Ideas...Continue reading
Ksana Health completed its first third-party assessment for security and privacy controls, receiving unqualified approval attesting to the strength of our controls and compliance with best practices and statutory requirements, including: AICPA,...Continue reading